CONNECT WITH US
HealthTech

HealthTech

'Game changer' blood test for CTE may be coming

Medical Xpress logo

Published on

Add as a preferred source on Google
'Game changer' blood test for CTE may be coming

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Traces of a brain protein in blood could soon lead to a test that could diagnose chronic traumatic encephalopathy (CTE) during a person's lifetime. CTE is a degenerative brain disease best known for affecting football players.

Right now, CTE can only be diagnosed via autopsy after death. One recent autopsy-based study found that nearly 75% of deceased former NFL players had been affected by CTE.

The illness is linked to repeat head injury and can lead to cognitive impairment, behavioral changes, mood swings and dementia.

A blood-based test that could spot CTE while players are still alive could be "a game changer," said study co-senior author Michael Alosco, co-director of clinical research at Boston University's CTE Center.

The test is not yet approved by the U.S. Food and Drug Administration (FDA).

"We are still in the discovery phase, and it's a small sample size, but if future studies validate these findings, this blood test will allow us to detect CTE with a high level of accuracy and open the doors to clinical trials and treatment," Alosco said in a university news release.

The researchers based their findings on blood tests conducted with 21 former American football players while they were still alive. All had donated their brains for research, and 18 of the players' brains revealed the presence of CTE.

The blood test is designed to spot traces of a brain protein abbreviated as eMTBR-tau.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.